期刊文献+

瘦素和脂联素在食管鳞癌中的表达及其临床意义 被引量:5

Expression of leptin and adiponectin in esophageal squamous cell carcinoma and their clinical significance
原文传递
导出
摘要 目的 初步探讨脂肪因子瘦素和脂联素在食管鳞癌(ESCC)中表达及其临床病理意义.方法 采用免疫组化方法检测ESCC组织和癌旁正常食管黏膜组织中瘦素和脂联素的表达情况,分析其与ESCC患者临床病理特征之间的相关性.结果 瘦素蛋白表达于ESCC和癌旁正常食管黏膜组织的细胞质和细胞膜中,脂联素蛋白表达于细胞核中.ESCC组织中瘦素蛋白阳性率为65.6%(80/122),食管正常黏膜组织中瘦素蛋白阳性率为27.5% (11/40),差异有统计学意义(P <0.001).ESCC组织中脂联素蛋白阳性率为22.1% (27/122),食管正常黏膜组织中脂联素蛋白阳性率为47.5% (19/40),差异有统计学意义(P =0.002).瘦素蛋白表达与ESCC淋巴结转移、TNM分期有关(P =0.009,P=0.043),脂联素蛋白表达与ESCC淋巴结转移有关(P =0.020).相关性分析显示,瘦素蛋白表达与ESCC淋巴结转移和TNM分期呈正相关(r=0.235,r=0.183),脂联素蛋白表达与ESCC淋巴结转移呈负相关(r=-0.229),瘦素蛋白表达与脂联素蛋白表达无关(P>0.05),体重指数(BMI)与瘦素、脂联素表达及淋巴结转移无关(均P>0.05).结论 ESCC组织中存在脂肪因子的失衡表达.瘦素蛋白过表达和脂联素蛋白低表达均与ESCC淋巴结转移相关.脂肪因子可能也参与了ESCC的发生与发展。 Objective To preliminarily investigate the expression and clinical significance of leptin and adiponectin in esophageal squamous cell carcinoma (ESCC).Methods The expression of leptin and adiponectin in ESCC and normal esophageal mucosal tissue was detected by immunohistochemical staining with tissue microarray.The correlation between leptin,adiponectin and clinicalpathological features was statistically analyzed.Results The expression of leptin was significantly upregulated in the ESCC than in the normal esophageal mucosa tissue [65.6% (80/122) versus 27.5 % (11/40),P 〈 0.001].Expression of leptin was significantly correlated with lymph node involvement and advanced tumor stage (P =0.009 and P =0.043,respectively).Expression of adiponectin was significantly down-regulated in ESCC compared with that in normal esophageal mucosal tissue [22.1% (27/122) versus 47.5% (19/40),P =0.002].Expression of adiponectin was significantly correlated with lymph node involvement (P =0.020).Correlation analysis showed a positive correlation between the expression of leptin and lymph node metastasis and TNM stage (r =0.235 and r =0.183,respectively),and a negative correlation between the expression of adiponectin and lymph node metastasis (r =-0.229).There was no significant correlation between the expressions of leptin and adiponectin (P 〉 0.05),and between the body mass index and the expression of leptin and adiponectin,and lymph node metastasis (P 〉 0.05 for all).Conclusions An imbalanced expression of adipocytokines exits in ESCC.The expression of leptin and adiponectin is correlated with lymph node metastasis and/or tumor stage.Therefore,imbalanced expression of leptin and adiponectin may have a potential role in the carcinogenesis and disease progression of ESCC.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2014年第11期839-843,共5页 Chinese Journal of Oncology
关键词 食管肿瘤 瘦素 脂联素 免疫组织化学 Esophageal neoplasms Leptin Adiponectin Immunohistochemistry
  • 相关文献

参考文献23

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) :69-90.
  • 2曾红梅,郑荣寿,张思维,赵平,赫捷,陈万青.1989-2008年中国恶性肿瘤死亡趋势分析[J].中华肿瘤杂志,2012,34(7):525-531. 被引量:100
  • 3Kamangar F, Dotes GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14) :2137-2150.
  • 4Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma[J]. Imcet, 2013, 381 (9864) :400-412.
  • 5Ryan AM, Duong M, Healy L, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets [J]. Cancer Epidemiol, 2011, 35(4):309-319.
  • 6Kubo A, Codey DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis [ J ]. Cancer Epidemiol Biomarkers Prey, 2006,15 ( 5 ) :872-878.
  • 7Navarre Silvem SA, Mayne ST, Risch HA, et al. Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer [ J ]. Ann Epidemiol, 2011, 21 (7) :543-550.
  • 8Kavanagh ME, O'Sullivan KE, O'Hanlon C, et al. The esophagitis to adenocarcinoma sequence; the role of inflammation [ J ]. Cancer Lett, 2014, 345(2) :182-189.
  • 9Kendall B J, Macdonald GA, Hayward NK, et al. Leptin and the risk of Barrett's oesophagus[J]. Gut, 2008, 57(4) :448-454.
  • 10Rubenstein JH, Dahlkemper A, Kan JY, et al. A pilot study of the association of low plasma adiponectin and Barrett's esophagus [J]. Am J Gastreenterol, 2008, 103(6) :1358-1364.

二级参考文献20

  • 1Calle EE, Thun MJ. Obesity and cancer. Oncogene, 2004, 23: 6365 -6378.
  • 2Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer, 2006, 13:279-292.
  • 3Yin N, Wang D, Zhang H, et al. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res, 2004, 64:5870-5875.
  • 4Gritsko T, Williams A, Turkson J, et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res, 2006, 12:11-19.
  • 5Konnikova L, Kotecki M, Kruger MM, et al. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer, 2003, 3:23.
  • 6Garofalo C, Surmacz E. Leptin and cancer. Cell Physiol, 2006, 207:12-22.
  • 7Garofalo C, Koda M, Cascio S, et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res, 2006, 12 : 1447-1453.
  • 8Zhu Y, Wang A, Liu MC, et al. Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. Int J Oncol, 2006, 29 : 1581-1589.
  • 9Peng XH, Karna P, Cao Z, et al. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-lalpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem, 2006, 281:25903-25914.
  • 10Bruno A, Conus S, Schmid I, et al. Apoptofic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol, 2005, 174 : 8090-8096.

共引文献103

同被引文献38

  • 1Ziemke F, Mantzoros C5. Adiponectin in insulin resistance: lessons from translational research [J]. Am J Clin Nutr, 2010, 91 (1): 2585-2615.
  • 2Paz-Filho G, Lim EL, Wong ML, et a1. Associations between adipokines and obesity-related cancer [J]. Front Biosci (Landmark Ed), 2011, 16: 1634-1650.
  • 3Simpson F, Whitehead JP. Adiponectin - it's all about the modifications [J]. Int J Biochem Cell BioI, 2010, 42 (6) : 785-788.
  • 4Ge H, Xiong Y, Lemon B, et a1. Generation of novel long-acting globular adiponectin molecules [J]. J Mol BioI, 2010,399 (1): 113-119.
  • 5Tilg H, Moschen AR. Adipocytokines , mediators linking adipose tissue, inflammation and immunity [J]. Nat Rev Immunol, 2006, 6 (10) : 772-783.
  • 6Brochu-Gaudreau K, Rehfeldt C, Blouin R, et al. Adiponectin action from head to toe [J]. Endocrine, 2010, 37 (1) : 11-32.
  • 7Holland WL, Miller RA, Wang ZV, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin[J]. Nat Med, 2011, l7 (1) : 55-63.
  • 8Takabe K, Paugh 5W, Milstien 5, et al. "Inside-out" signaling of sphingosine-I-phosphate: therapeutic targets [J]. Pharmacol Rev, 2008, 60 (2): 181-195.
  • 9Miyazaki T, Bub JD, Uzuki M, et al. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3 [J]. Biochem Biophys Res Commun, 2005, 333 (1) : 79-87.
  • 10Deepa SS, Dong LQ. APPLl: role in adiponectin signaling and beyond [J]. Am J Physiol Endocrinol Metab, 2009, 296 (1): E22-E36.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部